PipelineReview.com - All Products

Show Cart

All Products

Results 21 - 40 of 194

Sep 2019 RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Jul 2019 CD137 Costimulatory Receptor Agonists – Target Pipeline List 07/2019

Jun 2019 CD38-Targeted Antibody & Cell Therapy – Target Pipeline List 06/2019

Jun 2019 Report Package: Bispecific Antibodies

(Discount: 20.00%)

Jun 2019 Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

Jun 2019 T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

May 2019 CD33-Targeted Antibody & Cell Therapy – Target Pipeline List 05/2019

Apr 2019 CD40 Agonists – Target Pipeline List 04/2019

Mar 2019 Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins

Jan 2019 DNA Vaccines for cancer, infectious & other diseases

Dec 2018 TFPI Inhibitors – Target Pipeline List

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

Aug 2018 CD40 Antagonists & CD40L Inhibitors – Target Pipeline List 08/2018

Aug 2018 Myostatin Inhibitors – Target Pipeline List 08/2018

Aug 2018 Interleukin-2 Receptor Agonists – Target Pipeline List 08/2018

Aug 2018 LRRK2 Inhibitors – Target Pipeline List 08/2018

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing